Skip to main content
SpringerLink
Log in

Transgender Identity and Sexually Transmitted Diseases Including HIV

  • Chapter
  • First Online:
Management of Gender Dysphoria

  • 2589 Accesses

Abstract

The term sexually transmitted diseases (STDs) is used to refer to a variety of clinical syndromes caused by pathogens that can be acquired and transmitted through sexual activity. STDs are among the most common infectious diseases, and human immunodeficiency virus (HIV) infection is of major public health importance worldwide. Transgender communities are among the groups at highest risk for HIV and other STD infections. The high burden of HIV infection among transgender people is not attributable only to individual behaviors but also to many cultural, socioeconomic, and health-related factors. HIV prevention involves combinations of behavioral strategies, early antiretroviral therapy (ART) after infection, preexposure and postexposure antiretroviral prophylaxis. The use of antiretroviral agents as postexposure prophylaxis (PEP) is the most important strategy for preventing occupationally acquired HIV infection among health-care workers (HCW).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kasper DL, Braunwald E (2005) Harrison’s principles of internal medicine, 16th edn. McGraw-Hill, New York

    Google Scholar 

  2. Hankins C (2013) Overview of the current state of the epidemic. Curr HIV/AIDS Rep 10:113–123

    Article  PubMed Central  PubMed  Google Scholar 

  3. HIV/AIDS surveillance in Europe 2012. http://www.euro.who.int/en/health-topics/communicable-diseases/hivaids/publications/2012/hivaids-surveillance-in-europe-2011

  4. UNAIDS (2012) Global report 2012 UNAIDS report on the global AIDS epidemic. United Nations Publications, Geneve

    Google Scholar 

  5. HIV among transgender people. http://www.cdc.gov/hiv/transgender/

  6. Institute of Medicine (2011) The health of lesbian, gay, bisexual and transgender people: building a foundation for better understanding. The National Academies Press, Washington, DC

    Google Scholar 

  7. New York City Department of Health and Mental Hygiene (2011) Surveillance slide sets: HIV among transgender persons in New York City, 2005–2009. Accessed Oct 2013

    Google Scholar 

  8. Herbst JH, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N (2008) Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav 12(1):1–17

    Article  PubMed  Google Scholar 

  9. Operario D, Soma T, Underhill K (2008) Sex work and HIV status among transgender women: systematic review and meta-analysis. J Acquir Immune Defic Syndr 48:97–103

    Article  PubMed  Google Scholar 

  10. Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C (2013) Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 13:214–222

    Article  PubMed  Google Scholar 

  11. Clements-Nolle K, Marx R, Guzman R, Katz M (2001) HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health 91:915–921

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Baggaley RF, White RG, Boily MC (2010) HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 39:1048–1063

    Article  PubMed Central  PubMed  Google Scholar 

  13. Coan DL, Schrager W, Packer T (2005) The role of male sexual partners in HIV infection among male-to-female transgendered individuals. Int J Transgenderism 8:21–30

    Article  Google Scholar 

  14. Vandepitte J, Lyerla R, Dallabetta G et al (2006) Estimates of the number of female sex workers in different regions of the world. Sex Transm Infect 82(Suppl 3):S18–S25

    Google Scholar 

  15. Beyrer C, Baral SD, van Griensven F et al (2012) Global epidemiology of HIV infection in men who have sex with men. Lancet 380:367–377

    Article  PubMed Central  PubMed  Google Scholar 

  16. Grant JM, Mottet LA, Tanis J, Harrison J, Herman JL, Keisling M (2011) Injustice at every turn: a report of the national transgender discrimination survey. The National Gay and Lesbian Task Force and the National Center for Transgender Equality, Washington, DC

    Google Scholar 

  17. Melendez RM, Pinto R (2007) ‘It’s really a hard life’: love, gender and HIV risk among male-to-female transgender persons. Cult Health Sex 9:233–245

    Article  PubMed Central  PubMed  Google Scholar 

  18. Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD (2013) Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet 382:1515–1524

    Article  CAS  PubMed  Google Scholar 

  19. Cohen MS, Chen YQ, McCauley M et al; the HPTN 059 Study Team (2011) Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365:493–505

    Google Scholar 

  20. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2013) http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html. Accessed 19 Aug 2013

  21. US Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents (2012): guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents (2012) http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadoloscentgl.pdf. Accessed 3 Aug 2013

  22. Mayer K, Gazzard B, Zuniga JM et al (2013) Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis. J Int Assoc Provid AIDS Care 12:208–216

    Article  PubMed  Google Scholar 

  23. Abdool Karim Q, Abdool Karim SS, Frohlich JA et al (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329:1168–1174

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Grant RM, Larna JM, Anderson PL et al (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363:2587–2599

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Baeten JM, Donnell D, Ndase P et al (2012) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 367:399–410

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Thigpen MC, Kebaabetswe PM, Paxton LA et al (2012) Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 367:423–434

    Article  CAS  PubMed  Google Scholar 

  27. Centers for Disease Control and Prevention (CDC) (2011) Interim guidance: preexposure prophylaxis for prevention of HIV infection in men who have sex with men. Morb Mortal Wkly Rep 60:65–68

    Google Scholar 

  28. Krakower D, Mayer KH (2012) What primary care providers need to know about preexposure prophylaxis for HIV prevention. Ann Intern Med 157:490–497

    Article  PubMed Central  PubMed  Google Scholar 

  29. Peinado J, Lama JR, Galea JT et al (2013) Acceptability of oral versus rectal HIV preexposure prophylaxis among men who have sex with men and transgender women in Peru. J Int Assoc Provid AIDS Care 12:278–283

    Article  PubMed  Google Scholar 

  30. Spira AI, Marx PA, Patterson BK et al (1996) Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 183:215–225

    Article  CAS  PubMed  Google Scholar 

  31. Smith DK, Grohskopf LA, Black RJ et al (2005) US Department of Health and Human Services. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep 54:1–20

    PubMed  Google Scholar 

  32. Cardo DM, Culver DH, Ciesielski CA et al (1997) A case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood: clinical and public health implications. N Engl J Med 337:1485–1490

    Article  CAS  PubMed  Google Scholar 

  33. Harrison LH, Lago RF, Moreira RI, Schechter M (2000) Demand for post-sexual-exposure chemoprophylaxis for the prevention of HIV infection in Brazil. 7th Conference on retroviruses and opportunistic infections, San Francisco, Jan 30–Feb 2 2000 (Abstract 492)

    Google Scholar 

  34. Benn P, Fisher M, Kulasegaram R (2011) UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure. Int J STD AIDS 22:695–708

    Article  CAS  PubMed  Google Scholar 

  35. McAllister J, Read P, McNulty A, Tong W, Ingersoll A, Carr A (2014) Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence. HIV Med 15:13–22

    Article  CAS  PubMed  Google Scholar 

  36. Millett GA, Flores SA, Marks G et al (2008) Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with man: a meta-analysis. JAMA 300:1674–1684

    Article  CAS  PubMed  Google Scholar 

  37. Grohskopf LA, Smith DK, Kunches LK et al (2002) Surveillance of post-exposure prophylaxis for non-occupational HIV exposures through the U.S. national registry. Presented at the XIV international conference on AIDS, Barcelona, July 7–12 2002 (Abstract MoOrD1107)

    Google Scholar 

  38. Tissot F, Erard V, Dang T, Cavassini M (2010) Nonoccupational HIV post-exposure prophylaxis: a ten year retrospective analysis. HIV Med 11:584–592

    Article  CAS  PubMed  Google Scholar 

  39. Centers for Disease Control and Prevention (1990) Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR Recomm Rep 39:1–14

    Google Scholar 

  40. Kuhar DT, Henderson DK, Struble KA et al (2013) Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 34:875–892

    Article  PubMed  Google Scholar 

  41. Bell DM (1997) Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 102:9–15

    Article  CAS  PubMed  Google Scholar 

  42. Ippolito G, Puro V, De Carli G, Italian Study Group on Occupational Risk of HIV infection (1993) The risk of occupational human immunodeficiency virus infection in health care workers: Italian multicenter study. Arch Intern Med 153:1451–1458

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Diseases Unit, University Hospital of Trieste, Piazza dell’Ospitale 1, Trieste, 34100, Italy

    Roberto Luzzati & Cristina Maurel

Authors
  1. Roberto Luzzati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristina Maurel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Luzzati .

Editor information

Editors and Affiliations

  1. Department of Urology, University of Trieste, Cattinara Hospital, Trieste, Italy

    Carlo Trombetta

  2. Department of Urology, University of Trieste, Cattinara Hospital, Trieste, Italy

    Giovanni Liguori

  3. Department of Radiology, University of Trieste, Cattinara Hospital, Trieste, Italy

    Michele Bertolotto

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this chapter

Cite this chapter

Luzzati, R., Maurel, C. (2015). Transgender Identity and Sexually Transmitted Diseases Including HIV. In: Trombetta, C., Liguori, G., Bertolotto, M. (eds) Management of Gender Dysphoria. Springer, Milano. https://doi.org/10.1007/978-88-470-5696-1_39

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5696-1_39

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5695-4

  • Online ISBN: 978-88-470-5696-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation